Simulations Plus Inc

NASDAQ:SLP USA Health Information Services
Market Cap
$240.15 Million
Market Cap Rank
#15079 Global
#5978 in USA
Share Price
$11.92
Change (1 day)
-1.65%
52-Week Range
$11.43 - $35.88
All Time High
$87.82
About

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans… Read more

Simulations Plus Inc (SLP) - Net Assets

Latest net assets as of November 2025: $127.11 Million USD

Based on the latest financial reports, Simulations Plus Inc (SLP) has net assets worth $127.11 Million USD as of November 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($137.83 Million) and total liabilities ($10.72 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $127.11 Million
% of Total Assets 92.22%
Annual Growth Rate 24.85%
5-Year Change -24.72%
10-Year Change 449.0%
Growth Volatility 295.19

Simulations Plus Inc - Net Assets Trend (1996–2025)

This chart illustrates how Simulations Plus Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Simulations Plus Inc (1996–2025)

The table below shows the annual net assets of Simulations Plus Inc from 1996 to 2025.

Year Net Assets Change
2025-08-31 $124.80 Million -31.59%
2024-08-31 $182.43 Million +7.29%
2023-08-31 $170.03 Million -4.61%
2022-08-31 $178.25 Million +7.52%
2021-08-31 $165.78 Million +6.25%
2020-08-31 $156.04 Million +314.09%
2019-08-31 $37.68 Million +18.04%
2018-08-31 $31.92 Million +23.71%
2017-08-31 $25.80 Million +13.51%
2016-08-31 $22.73 Million +16.39%
2015-08-31 $19.53 Million +26.54%
2014-08-31 $15.44 Million +8.38%
2013-08-31 $14.24 Million -5.94%
2012-08-31 $15.14 Million +7.88%
2011-08-31 $14.04 Million +7.59%
2010-08-31 $13.05 Million +23.41%
2009-08-31 $10.57 Million +6.61%
2008-08-31 $9.92 Million +29.36%
2007-08-31 $7.66 Million +35.21%
2006-08-31 $5.67 Million +16.59%
2005-08-31 $4.86 Million +9.36%
2004-08-31 $4.45 Million +35.58%
2003-08-31 $3.28 Million +327.03%
2002-08-31 $767.88K +171.37%
2001-08-31 $282.97K -41.78%
2000-08-31 $486.07K -34.37%
1999-08-31 $740.66K -42.31%
1998-08-31 $1.28 Million -61.71%
1997-08-31 $3.35 Million +1576.52%
1996-08-31 $200.00K --

Equity Component Analysis

This analysis shows how different components contribute to Simulations Plus Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 17282.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (August 2025)

Component Amount Percentage
Common Stock $20.00K 0.02%
Other Comprehensive Income $-271.00K -0.22%
Other Components $159.42 Million 127.74%
Total Equity $124.80 Million 100.00%

Simulations Plus Inc Competitors by Market Cap

The table below lists competitors of Simulations Plus Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Simulations Plus Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 182,431,000 to 124,801,000, a change of -57,630,000 (-31.6%).
  • Net loss of 64,718,000 reduced equity.
  • Other comprehensive income decreased equity by 20,000.
  • Other factors increased equity by 7,108,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $-64.72 Million -51.86%
Other Comprehensive Income $-20.00K -0.02%
Other Changes $7.11 Million +5.7%
Total Change $- -31.59%

Book Value vs Market Value Analysis

This analysis compares Simulations Plus Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.92x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 132.44x to 1.92x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1996-08-31 $0.09 $11.92 x
1997-08-31 $1.14 $11.92 x
1998-08-31 $0.39 $11.92 x
1999-08-31 $0.05 $11.92 x
2000-08-31 $0.04 $11.92 x
2001-08-31 $0.02 $11.92 x
2002-08-31 $0.05 $11.92 x
2003-08-31 $0.22 $11.92 x
2004-08-31 $0.29 $11.92 x
2005-08-31 $0.31 $11.92 x
2006-08-31 $0.35 $11.92 x
2007-08-31 $0.43 $11.92 x
2008-08-31 $0.55 $11.92 x
2009-08-31 $0.62 $11.92 x
2010-08-31 $0.79 $11.92 x
2011-08-31 $0.87 $11.92 x
2012-08-31 $0.94 $11.92 x
2013-08-31 $0.87 $11.92 x
2014-08-31 $0.94 $11.92 x
2015-08-31 $1.15 $11.92 x
2016-08-31 $1.32 $11.92 x
2017-08-31 $1.47 $11.92 x
2018-08-31 $1.79 $11.92 x
2019-08-31 $2.09 $11.92 x
2020-08-31 $8.42 $11.92 x
2021-08-31 $7.99 $11.92 x
2022-08-31 $8.59 $11.92 x
2023-08-31 $8.31 $11.92 x
2024-08-31 $8.99 $11.92 x
2025-08-31 $6.21 $11.92 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Simulations Plus Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -51.86%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -81.74%
  • • Asset Turnover: 0.60x
  • • Equity Multiplier: 1.06x
  • Recent ROE (-51.86%) is below the historical average (-0.09%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1997 -42.84% -57.62% 0.66x 1.13x $-1.77 Million
1998 -163.58% -80.77% 1.29x 1.57x $-2.23 Million
1999 -77.86% -16.63% 2.15x 2.18x $-650.73K
2000 -53.00% -7.10% 2.48x 3.02x $-306.21K
2001 -79.73% -5.76% 3.11x 4.44x $-253.90K
2002 63.15% 10.91% 2.80x 2.07x $408.13K
2003 76.43% 45.69% 1.38x 1.21x $2.18 Million
2004 18.81% 16.07% 0.98x 1.19x $391.89K
2005 5.40% 5.52% 0.79x 1.25x $-223.90K
2006 11.92% 11.54% 0.81x 1.27x $109.02K
2007 19.13% 16.55% 0.95x 1.22x $699.64K
2008 17.40% 19.24% 0.77x 1.17x $734.06K
2009 13.36% 15.44% 0.74x 1.17x $355.00K
2010 16.53% 20.13% 0.73x 1.12x $851.49K
2011 19.34% 31.06% 0.55x 1.13x $1.31 Million
2012 20.00% 32.05% 0.54x 1.15x $1.51 Million
2013 20.27% 28.66% 0.63x 1.13x $1.46 Million
2014 19.60% 26.40% 0.55x 1.36x $1.48 Million
2015 19.68% 20.98% 0.67x 1.40x $1.89 Million
2016 21.78% 24.79% 0.72x 1.22x $2.68 Million
2017 22.43% 23.98% 0.63x 1.49x $3.21 Million
2018 27.99% 30.12% 0.67x 1.38x $5.74 Million
2019 22.78% 25.27% 0.74x 1.22x $4.81 Million
2020 5.98% 22.44% 0.24x 1.09x $-6.27 Million
2021 5.90% 21.05% 0.26x 1.10x $-6.80 Million
2022 7.00% 23.16% 0.28x 1.07x $-5.34 Million
2023 5.86% 16.72% 0.31x 1.13x $-7.04 Million
2024 5.46% 14.22% 0.34x 1.14x $-8.29 Million
2025 -51.86% -81.74% 0.60x 1.06x $-77.20 Million

Industry Comparison

This section compares Simulations Plus Inc's net assets metrics with peer companies in the Health Information Services industry.

Industry Context

  • Industry: Health Information Services
  • Average net assets among peers: $79,108,599
  • Average return on equity (ROE) among peers: -247.59%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Simulations Plus Inc (SLP) $127.11 Million -42.84% 0.08x $198.40 Million
Accolade, Inc. (ACCD) $473.79 Million -97.02% 0.91x $448.32 Million
Achiko AG (ACHKF) $-4.58 Million 0.00% 0.00x $314.42K
Ascom Holding AG (ACMLF) $78.70 Million 22.11% 1.51x $152.13 Million
Accelera Innovations Inc (ACNV) $-462.52K 0.00% 0.00x $5.72K
Aclarion Inc (ACON) $-7.08 Million 0.00% 0.00x $1.89 Million
Alternate Health Corp (AHGIF) $1.07 Million -2231.82% 7.94x $6.50K
AI/ML Innovations Inc (AIMLF) $2.09 Million -130.52% 0.72x $6.84 Million
NetraMark Holdings Inc. (AINMF) $-198.56K 0.00% 0.00x $70.13 Million
AMJ Global Technology (AMJT) $-21.78K 0.00% 0.00x $10.99 Million
American Well Corp (AMWL) $247.79 Million -38.62% 0.31x $78.62 Million